UNSPSC 51242101: Anethole/capsicum/glycyrrhiza/peppermint oil

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class NT900. This VA Drug Class (NT900) classifies this compound as belonging to the group NASAL AND THROAT, TOPICAL, OTHER.

UNSPSC 51242101 Anethole/capsicum/glycyrrhiza/peppermint oil (Commodity) covers botanical and herbal oil products for use in pharmaceutical and over-the-counter formulations distributed through state and local government health and human services networks. State and local buyers source these products as ingredients or finished goods within broader pharmaceutical procurement frameworks, typically bundled with multi-source generic and OTC product agreements. The issuing bodies are primarily cooperative purchasing alliances operating on behalf of multiple participating state and local jurisdictions — Minnesota's MMCAP being a representative model — rather than individual agencies. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain relationships with authorized pharmaceutical wholesalers, and carry comprehensive liability insurance including commercial general liability of at least $5,000,000 per occurrence and network security and privacy liability of $2,000,000.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products serving participating state and local facilities including Oregon. Awarded vendors will be required to supply products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — with contractual effectiveness July 1, 2026. Evaluation weights pricing competitiveness at 75 percent, fixed pricing at 10 percent, compliance with administrative fee data format and EDI capability at 5 percent each, and agreement to a 3 percent administrative fee at 5 percent. Products must comply with FDA requirements, possess expiration dates at least one year from manufacture, and maintain a minimum six-month shelf life. MMCAP reserves the right to make sole, dual, or multi-awards based on therapeutic considerations, product availability, and member-specific needs; no specific award values or budget ranges were disclosed in the solicitation materials.